Navigation Links
US Oncology Welcomes New Director of Federal Government Relations
Date:4/24/2008

Geoff Werth to Lead Expansion of Organization's DC-Based Legislative Initiatives

WASHINGTON, April 24 /PRNewswire-USNewswire/ -- The US Oncology Government Relations and Public Policy department announced today the appointment of Geoff Werth to its newly created Director of Federal Government Relations position. Based in the organization's Washington, D.C. office, Werth will focus on extending US Oncology's reach on Capitol Hill in order to advance public policies designed to improve the delivery of high-quality community-based cancer treatment and cancer research nationwide.

"We are pleased to have Geoff join our government relations team at US Oncology, and we look forward to working with him to expand upon our current programs that are advancing quality cancer care across America," said Dan Cohen, Senior Vice President of Government Relations and Public Policy, US Oncology. "With his unique background as a passionate healthcare advocate, legislative staffer and trained medical technician, we are fortunate to have him on board."

With more than 10 years of experience in the legislative arena, including most recently spending nearly four years as a lobbyist in the Washington, D.C. office of the American College of Surgeons (ACS), Werth is well positioned to bring new leadership to US Oncology's public policy initiatives. Prior to his time with ACS, Werth worked on Capitol Hill for Congressman Bart Stupak (D-MI), Chairman of the House Energy and Commerce Committee's Oversight and Investigations Subcommittee; and in the leadership office of Minority Leader Dick Gephardt (D-MO). He also has experience in the healthcare field and is trained as a medical technologist.

"I look forward to applying my experience in federal legislative and medical affairs toward new opportunities with US Oncology," said Werth. "Advancing cancer care is one of the most pressing challenges our nation faces today, and I am proud to be working with an organization on the forefront of improving treatment and research quality on behalf of millions of patients and their families."

A Kansas native, Werth holds a Bachelors degree from Kansas University and a Masters in Public Policy from the University of Maryland. He lives in Washington, D.C. with his wife, Amanda.

About US Oncology

US Oncology is the nation's leading healthcare services network dedicated exclusively to cancer treatment and research. We provide physicians with extensive services and support. US Oncology is affiliated with more than 1,000 physicians practicing in approximately 440 locations, including over 90 cancer centers and radiation facilities in 39 states.


'/>"/>
SOURCE US Oncology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
2. ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration
3. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference
4. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
5. US Oncology to Report 2007 Third Quarter Earnings Results
6. VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting
7. Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines
8. Varian Medical Systems Ranks First in Overall Service Performance in 2007 Survey of U.S. Radiation Oncology Professionals
9. Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting
10. Debiopharm and NanoCarrier Sign License and Supply Agreement for Dach-Platin Polymeric Micelle in Oncology
11. National Autism Association and Deirdre Imus Environmental Center for Pediatric Oncology Announce National Greening Your School Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... a breakthrough topical cream that’s the first in a new class of photodynamic ... the overall appearance of skin, visibly reduce outward signs of aging, and minimize ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges ... for how his administration could impact the employee benefits industry. James Slotnick, AVP, ... most likely to make it through Congress. His discussion will focus on the ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... rely on contracted partners to help with process innovation in drug formulation and ... formulation experience along with state-of-the-art analytical equipment in support of their development and ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College is introducing ... advance their careers. Beginning in the fall of 2017, Emmanuel’s program will allow registered ... few as 16 months and for as little as $14,528. These changes will enable ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... India , April 19, 2017 ... and Application, Forecast to 2022 report has covered and analysed ... statistics and information on market size, shares and growth factors. ... major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and Figures, ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/19/2017)... , April 19, 2017  Novartis today ... the National Heart, Lung, and Blood Institute (NHLBI) ... that 58% of patients with treatment-naïve severe aplastic ... when treated with eltrombopag at the initiation of ... The study evaluated three sequential treatment groups, or ...
Breaking Medicine Technology: